We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
VRTS | Gamelancer Media Corp | 0.03 | 0.005 | 20.00% | 193,130 |
FTU | US Financial 15 Split Corp | 0.38 | 0.05 | 15.15% | 29,050 |
HUT | Hut 8 Corp | 12.63 | 1.54 | 13.89% | 1,711,492 |
IVQ.U | Invesque Inc | 0.225 | 0.025 | 12.50% | 1,000 |
BKI | Black Iron Inc | 0.05 | 0.005 | 11.11% | 74,000 |
EPRX | Eupraxia Pharmaceuticals Inc | 4.04 | 0.34 | 9.19% | 72,753 |
TMD | Titan Medical Inc | 0.06 | 0.005 | 9.09% | 83,195 |
HBP | Helix BioPharma Corp | 0.19 | 0.015 | 8.57% | 2,000 |
QIPT | Quipt Home Medical Corp | 5.13 | 0.39 | 8.23% | 46,987 |
DC.A | Dundee Corporation | 1.28 | 0.09 | 7.56% | 21,710 |
BU | Burcon NutraScience Corporation | 0.215 | 0.015 | 7.50% | 32,623 |
All amounts are in CAD unless stated otherwise Sets the stage for the creation of a leading intermediate gold producer with the addition of Oko West, one of the most significant gold discoveries in the Guiana Shield, to GMIN's portfolioLed by GMIN's best-in class management team, ideally positioned to unlock the value of Oko WestThe GMIN team and GMS have an impressive track-record of executing world-class projects in the Guiana Shield region to generate industry leading returns for its stakeholdersDe-risked growth profile to accelerate development of Oko West through anticipated TZ cash flowCompelling re-rate potential from multiple near-term catalysts and enhanced capital markets profileContinued ...
Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI) is pleased to announce that, further to its news release dated March 22, 2024, it has closed three tranches of its non-brokered private placement through the sale of 4,263,263 units (“CDN Units”) at a price of CDN$0.55 per CDN Unit, raising gross proceeds of CDN$2,344,795, and 1,525,000 Chess Depository Interests units (“CDI Units”) at a price of A$0.62 per CDI Unit, raising gross proceeds of A$945,000.
TORONTO, April 22, 2024 /CNW/ - CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living communities, hosted the Honourable Doug Ford, Premier of Ontario, at the Company's Oakville pharmacy on April 18, 2024, to showcase CareRx's leadership in technology and innovation in support of improving healthcare outcomes for residents in long-term care homes across Ontario.
CALGARY, AB, April 22, 2024 /CNW/ - SC2 Inc. ("SC2") is pleased to announce that 16,899,224 common shares of Sherritt International Corporation (TSX: S) ("Sherritt"), representing 4.25% of the Sherritt public float, have already been tendered to the previously announced offer by SC2 to purchase up to 21,621,621 common shares of Sherritt, at a price of $0.37 per common share (the "Offer").
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
PSRU | Valiant Eagle Inc | 135 | |
AGBA | AGBA Group Holding Ltd | 75 | |
AVXL | Anavex Life Sciences Corp | 81 | |
4 | DRNK | NoHo Inc | 47 |
5 | SPZI | SPOOZ Inc | 128 |
6 | LEHNQ | Lehman Brothers Financial SA | 92 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 66,551.98 | -305.97 | -0.46% | 1.31T | 3,737,406,559 |
ETH | Ethereum | 3,185.99 | -16.07 | -0.50% | 382.94B | 1,652,190,112 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 395,371,963 |
BNB | Binance Coin | 602.12 | -2.98 | -0.49% | 95.22B | 344,504,993 |
SOL | Solana | 155.14 | -1.87 | -1.19% | 68.6B | 1,191,886,296 |
STETH | stETH | 3,169.41 | -31.05 | -0.97% | 31.1B | 3,272,649 |
XRP | Ripple | 0.5489 | -0.0077 | -1.38% | 30B | 452,192,623 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 994,662,024 |
DOGE | Dogecoin | 0.15883 | -0.0024 | -1.49% | 22.74B | 382,383,625 |
TONCOIN | Wrapped TON Coin | 5.80 | -0.107381 | -1.82% | 20.14B | 105,322,481 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions